XM does not provide services to residents of the United States of America.
B
B

BectonDickinson

News

Bd Increases Domestic Production To Support U.S. Health Care Need For Syringes

BRIEF-Bd Increases Domestic Production To Support U.S. Health Care Need For Syringes March 21 (Reuters) - Becton Dickinson and Co BDX.N : BD INCREASES DOMESTIC PRODUCTION TO SUPPORT U.S. HEALTH CARE NEED FOR SYRINGES Source text for Eikon: ID:nPn2rY01ca Further company coverage: BDX.N
B

Becton Dickinson ramps up syringe production in US amid China quality concerns

UPDATE 3-Becton Dickinson ramps up syringe production in US amid China quality concerns Adds FDA statement in paragraphs 6 and 7 March 21 (Reuters) - Becton Dickinson BDX.N said on Thursday it has increased production of medical syringes in the United States after the country's drug regulator recommended not using some China-made syringes as part of its ongoing quality probe.
B

Becton Dickinson to increase domestic production of syringes

Becton Dickinson to increase domestic production of syringes March 21 (Reuters) - Becton Dickinson BDX.N said on Thursday that it will increase domestic production of medical syringes. Reporting by Sneha S K; Editing by Tasim Zahid
B

Dave Hickey Announces Intent To Retire From BD

BRIEF-Dave Hickey Announces Intent To Retire From BD Feb 27 (Reuters) - Becton Dickinson and Co BDX.N : DAVE HICKEY ANNOUNCES INTENT TO RETIRE FROM BD Source text for Eikon: ID:nPn9kYh7ha Further company coverage: BDX.N
B

BD Partners With Camtech Health To Increase Access To Cervical Cancer Screening In Singapore

BRIEF-BD Partners With Camtech Health To Increase Access To Cervical Cancer Screening In Singapore Feb 21 (Reuters) - Becton Dickinson and Co BDX.N : BD PARTNERS WITH CAMTECH HEALTH TO INCREASE ACCESS TO CERVICAL CANCER SCREENING IN SINGAPORE Source text for Eikon: ID:nPnb55S70a Further company coverage: BDX.N
B

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.